108 STAT. 5552 PROCLAMATION 6664—APR. 7, 1994 NOW, THEREFORE, I, WILLIAM J. CLINTON, President of the United States of America, do hereby proclaim April 9, 1994, as National Former Prisoner of War Recognition Day. I urge all American citizens to join in honoring members of the Armed Forces of the United States who have been held as prisoners of war. I also call upon Federal, State, and local government officials and private organizations to observe this day wiiti appropriate ceremonies and activities. IN WITNESS WHEREOF, I have hereunto set my hand this sixth day of April, in the year of OMI Lord nineteen hundred and ninety-four, and of the Independence of the United States of America the two hundred and eighteenth. WILLIAM J. CLINTON Proclamation 6664 of April 7, 1994 Cancer Control Month, 1994 By the President of the United States of America A Proclamation April 1994 has been designated Cancer Control Month. For the past 56 years, the President of the United States, at the request of the Congress, has designated one month each year to focus public attention on the progress that we, as a Nation, have made with regard to this devastating disease. This Proclamation continues to be a national statement of hope that one day we will understand, control, and eliminate cancer. It would be hard to exaggerate the toll cancer exacts. Each year more than 1 million Americans are diagnosed with cancer, and nearly onehalf that many die of the disease. We face an awesome challenge in controlling cancer—one that can be met only through research and the implementation of research results. Breast cancer is the most common cancer among American women and epitomizes the challenge of our mission to protect and improve women's health. Breast cancer is widely prevalent and takes a tragically large toll on women's lives. Yet there are realistic prospects for its eventual prevention and cure. The strategies used to foster the translation of scientific knowledge into clinical innovations toward eradicating breast cancer also serve as prototypes for the treatment of other malignancies. Likewise, prostate cancer is the most frequently diagnosed cancer among men and the second leading cause of male cancer deaths. Researchers continue to direct their efforts toward understanding the biology of this disease in order to design more effective therapies, search for more effective screening methods, and ultimately, prevent its occurrence. The National Cancer Institute, the American Cancer Society, and other organizations are intensifying the effort in cancer prevention research. Programs to identify environmental and occupational causes of malignancy continue to be at the forefront of this research. Cinrent studies address the links between cancer risks and exposure to pesticides, proximity to sources of environmental toxins and occupational car-
�
